{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,14]],"date-time":"2026-04-14T16:36:48Z","timestamp":1776184608317,"version":"3.50.1"},"reference-count":14,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,5,22]],"date-time":"2023-05-22T00:00:00Z","timestamp":1684713600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,5,22]],"date-time":"2023-05-22T00:00:00Z","timestamp":1684713600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"EFSD\/Novo Nordisk Foundation Future Leaders Awards","award":["NNF22SA0081227"],"award-info":[{"award-number":["NNF22SA0081227"]}]},{"name":"Swedish Heart and Lung Foundation","award":["20200326 and 20220264"],"award-info":[{"award-number":["20200326 and 20220264"]}]},{"DOI":"10.13039\/501100004047","name":"Karolinska Institute","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100004047","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Purinergic Signalling"],"published-print":{"date-parts":[[2024,2]]},"abstract":"<jats:title>Abstract\n<\/jats:title><jats:p>Heart failure is associated with multiple mechanisms, including sympatho-excitation, and is one of the leading causes of death worldwide. Enhanced carotid body chemoreflex function is strongly related to excessive sympathetic nerve activity and sleep-disordered breathing in heart failure. How to reduce the excitability of the carotid body is still scientifically challenging. Both clinical and experimental evidence have suggested that targeting purinergic receptors is of great potential to combat heart failure. In a recent study, Lataro et al. (Lataro et al. in Nat Commun 14:1725, 5) demonstrated that targeting purinergic P2X<jats:sub>3<\/jats:sub> receptors in the carotid body attenuates the progression of heart failure. Using a series of molecular, biochemical, and functional assays, the authors observed that the carotid body generates spontaneous, episodic burst discharges coincident with the onset of disordered breathing in male rats with heart failure, which was generated by ligating the left anterior descending coronary artery. Moreover, P2X<jats:sub>3<\/jats:sub> receptor expression was found to be upregulated in the petrosal ganglion chemoreceptive neurons of rats with heart failure. Of particular note, treatment with a P2X<jats:sub>3<\/jats:sub> antagonist rescued pathological breathing disturbances, abolished episodic discharges, reinstated autonomic balance, attenuated cardiac dysfunction, and reduced the immune cell response and plasma cytokine levels in those rats.<\/jats:p>","DOI":"10.1007\/s11302-023-09945-y","type":"journal-article","created":{"date-parts":[[2023,5,22]],"date-time":"2023-05-22T03:09:36Z","timestamp":1684724976000},"page":"5-8","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Purinergic P2X3 receptors in the carotid body as new therapeutic targets for controlling heart failure"],"prefix":"10.1007","volume":"20","author":[{"given":"Ximeng","family":"He","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5107-6529","authenticated-orcid":false,"given":"Zhichao","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2023,5,22]]},"reference":[{"issue":"3","key":"9945_CR1","doi-asserted-by":"publisher","first-page":"1177","DOI":"10.1152\/physrev.00039.2019","volume":"101","author":"R Iturriaga","year":"2021","unstructured":"Iturriaga R, Alcayaga J, Chapleau MW, Somers VK (2021) Carotid body chemoreceptors: physiology, pathology, and implications for health and disease. Physiol Rev 101(3):1177\u20131235. https:\/\/doi.org\/10.1152\/physrev.00039.2019","journal-title":"Physiol Rev"},{"issue":"3","key":"9945_CR2","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1002\/ejhf.641","volume":"19","author":"P Niewinski","year":"2017","unstructured":"Niewinski P, Janczak D, Rucinski A, Tubek S, Engelman ZJ, Piesiak P, Jazwiec P, Banasiak W, Fudim M, Sobotka PA, Javaheri S, Hart EC, Paton JF, Ponikowski P (2017) Carotid body resection for sympathetic modulation in systolic heart failure: results from first-in-man study. Eur J Heart Fail 19(3):391\u2013400. https:\/\/doi.org\/10.1002\/ejhf.641","journal-title":"Eur J Heart Fail"},{"issue":"1","key":"9945_CR3","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1161\/CIRCRESAHA.116.309726","volume":"120","author":"G Burnstock","year":"2017","unstructured":"Burnstock G (2017) Purinergic signaling in the cardiovascular system. Circ Res 120(1):207\u2013228. https:\/\/doi.org\/10.1161\/CIRCRESAHA.116.309726","journal-title":"Circ Res"},{"issue":"4","key":"9945_CR4","doi-asserted-by":"publisher","first-page":"H723","DOI":"10.1152\/ajpheart.00417.2020","volume":"319","author":"B Wernly","year":"2020","unstructured":"Wernly B, Zhou Z (2020) More purinergic receptors deserve attention as therapeutic targets for the treatment of cardiovascular disease. Am J Physiol Heart Circ Physiol 319(4):H723\u2013H729. https:\/\/doi.org\/10.1152\/ajpheart.00417.2020","journal-title":"Am J Physiol Heart Circ Physiol"},{"issue":"1","key":"9945_CR5","doi-asserted-by":"publisher","first-page":"1725","DOI":"10.1038\/s41467-023-37077-9","volume":"14","author":"RM Lataro","year":"2023","unstructured":"Lataro RM, Moraes DJA, Gava FN, Omoto ACM, Silva CAA, Brognara F, Alflen L, Braz\u00e3o V, Colato RP, de Prado JC, Ford AP, Salgado HC, Paton JFR (2023) P2X3 receptor antagonism attenuates the progression of heart failure. Nat Commun 14(1):1725. https:\/\/doi.org\/10.1038\/s41467-023-37077-9","journal-title":"Nat Commun"},{"issue":"8","key":"9945_CR6","doi-asserted-by":"publisher","first-page":"913","DOI":"10.3389\/fphar.2017.00913","volume":"12","author":"SV Conde","year":"2017","unstructured":"Conde SV, Monteiro EC, Sacramento JF (2017) Purines and carotid body: new roles in pathological conditions. Front Pharmacol 12(8):913. https:\/\/doi.org\/10.3389\/fphar.2017.00913","journal-title":"Front Pharmacol"},{"issue":"6","key":"9945_CR7","doi-asserted-by":"publisher","first-page":"1270","DOI":"10.1097\/ALN.0b013e3181fac061","volume":"113","author":"MJ Fagerlund","year":"2010","unstructured":"Fagerlund MJ, K\u00e5hlin J, Ebberyd A, Schulte G, Mkrtchian S, Eriksson LI (2010) The human carotid body: expression of oxygen sensing and signaling genes of relevance for anesthesia. Anesthesiology 113(6):1270\u20131279. https:\/\/doi.org\/10.1097\/ALN.0b013e3181fac061","journal-title":"Anesthesiology"},{"issue":"10","key":"9945_CR8","doi-asserted-by":"publisher","first-page":"1151","DOI":"10.1038\/nm.4173","volume":"22","author":"W Pijacka","year":"2016","unstructured":"Pijacka W, Moraes DJ, Ratcliffe LE, Nightingale AK, Hart EC, da Silva MP, Machado BH, McBryde FD, Abdala AP, Ford AP, Paton JF (2016) Purinergic receptors in the carotid body as a new drug target for controlling hypertension. Nat Med 22(10):1151\u20131159. https:\/\/doi.org\/10.1038\/nm.4173","journal-title":"Nat Med"},{"issue":"Pt 3","key":"9945_CR9","doi-asserted-by":"publisher","first-page":"667","DOI":"10.1111\/j.1469-7793.2001.00667.x","volume":"537","author":"M Prasad","year":"2001","unstructured":"Prasad M, Fearon IM, Zhang M, Laing M, Vollmer C, Nurse CA (2001) Expression of P2X2 and P2X3 receptor subunits in rat carotid body afferent neurones: role in chemosensory signalling. J Physiol 537(Pt 3):667\u2013677. https:\/\/doi.org\/10.1111\/j.1469-7793.2001.00667.x","journal-title":"J Physiol"},{"issue":"5","key":"9945_CR10","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1054\/ceca.2000.0194","volume":"29","author":"D Pubill","year":"2001","unstructured":"Pubill D, Dayanithi G, Siatka C, Andr\u00e9s M, Dufour MN, Guillon G, Mendre C (2001) ATP induces intracellular calcium increases and actin cytoskeleton disaggregation via P2x receptors. Cell Calcium 29(5):299\u2013309. https:\/\/doi.org\/10.1054\/ceca.2000.0194","journal-title":"Cell Calcium"},{"issue":"2","key":"9945_CR11","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1016\/j.mcn.2007.10.001","volume":"37","author":"K Homma","year":"2008","unstructured":"Homma K, Niino Y, Hotta K, Oka K (2008) Ca(2+) influx through P2X receptors induces actin cytoskeleton reorganization by the formation of cofilin rods in neurites. Mol Cell Neurosci 37(2):261\u2013270. https:\/\/doi.org\/10.1016\/j.mcn.2007.10.001","journal-title":"Mol Cell Neurosci"},{"issue":"1","key":"9945_CR12","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1016\/j.jphs.2019.09.006","volume":"141","author":"C Sun","year":"2019","unstructured":"Sun C, Jiao T, Merkus D, Duncker DJ, Mustafa SJ, Zhou Z (2019) Activation of adenosine A2A but not A2B receptors is involved in uridine adenosine tetraphosphate-induced porcine coronary smooth muscle relaxation. J Pharmacol Sci 141(1):64\u201369. https:\/\/doi.org\/10.1016\/j.jphs.2019.09.006","journal-title":"J Pharmacol Sci"},{"key":"9945_CR13","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.yjmcc.2020.02.004","volume":"140","author":"R Zhou","year":"2020","unstructured":"Zhou R, Dang X, Sprague RS, Mustafa SJ, Zhou Z (2020) Alteration of purinergic signaling in diabetes: focus on vascular function. J Mol Cell Cardiol 140:1\u20139. https:\/\/doi.org\/10.1016\/j.yjmcc.2020.02.004","journal-title":"J Mol Cell Cardiol"},{"issue":"1","key":"9945_CR14","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1016\/j.jds.2021.06.007","volume":"17","author":"SH Seol","year":"2022","unstructured":"Seol SH, Chung G (2022) Estrogen-dependent regulation of transient receptor potential vanilloid 1 (TRPV1) and P2X purinoceptor 3 (P2X3): implication in burning mouth syndrome. J Dent Sci 17(1):8\u201313. https:\/\/doi.org\/10.1016\/j.jds.2021.06.007","journal-title":"J Dent Sci"}],"container-title":["Purinergic Signalling"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11302-023-09945-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11302-023-09945-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11302-023-09945-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,1,31]],"date-time":"2024-01-31T05:11:59Z","timestamp":1706677919000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11302-023-09945-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,5,22]]},"references-count":14,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2024,2]]}},"alternative-id":["9945"],"URL":"https:\/\/doi.org\/10.1007\/s11302-023-09945-y","relation":{},"ISSN":["1573-9538","1573-9546"],"issn-type":[{"value":"1573-9538","type":"print"},{"value":"1573-9546","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,5,22]]},"assertion":[{"value":"27 April 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 May 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 May 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This article does not contain any studies with human participants or animals performed by any of the authors.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"NA","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"The authors declare no competing interests.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}